You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Guatemala

May 2012

Price: US$2,400

About this Report

EXECUTIVE SUMMARY

Positive performance and growing consumption

In 2011, consumer health products continued to perform strongly, especially when compared to the review period as a whole. Sales have stabilised and are not experiencing the large jumps that were seen in some categories in 2010 as Guatemala recovered from the negative effects suffered during the economic downturn. Per capita consumption of most categories continues to increase, especially as more customers become interested in and are able to purchase consumer health products.

Innovation remains important for growth

Many categories within consumer health experienced innovation in 2011. Development of new products boosted the performance of both incipient as well as mature areas of the market. In the case of more mature and less dynamic categories, product innovation was a common mechanism to promote growth. Segmentation, promotion based on positioning and advertising were very important for new product launches and their success on the market.

Most categories remain dominated by multinationals

Multinationals maintained a leading position in many consumer health categories. These companies are able to compete with economies of scale accomplished by their participation in different markets. Multinationals are also commonly leading in terms of new product developments as they have international research and development teams at their disposal. Competition from certain domestic players has become important over the last few years, especially as these companies are able to more accurately capture and deliver what local consumers want. These companies however, sometimes fall short in terms of financial support needed for advertising and innovation.

Price war affecting one of the main distribution channels

Health specialist retailers are one of the main pillars for distribution of many consumer health products in Guatemala. The channel was affected in 2011 by a price war brought on by the economic downturn in 2009 that initially only affected lower-end retailers, but that continued to gain importance over 2010-2011, even reaching higher-end outlets. This price war affected some categories more than others, causing a flat-lining of current unit prices, as health specialist retailers are now offering an automatic 30% discount on all purchases paid for with cash.

Changing demographics versus difficult socioeconomic panorama

Future forecast performance is expected to be good for most consumer health categories in Guatemala. Future potential performance is balanced between good opportunities created by changing demographic characteristics and pre-existing challenging socioeconomic conditions. Urbanisation, higher disposable incomes, higher remittances, more job opportunities, and changing consumer lifestyles, among other factors, are creating great opportunities for future potential. However, companies must still take into account the fact that a large percentage of the population continues to live in poverty and cannot easily be considered as potential customers due to their limited purchasing power.


Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Guatemala with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Guatemala, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Guatemala for free:

The Consumer Health in Guatemala market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Guatemala?
  • What are the major brands in Guatemala?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Table of Contents

Table of Contents

Consumer Health in Guatemala - Industry Overview

EXECUTIVE SUMMARY

Positive performance and growing consumption

Innovation remains important for growth

Most categories remain dominated by multinationals

Price war affecting one of the main distribution channels

Changing demographics versus difficult socioeconomic panorama

KEY TRENDS AND DEVELOPMENTS

Potential is growing but certain economic conditions still limit performance

Marketing and advertising; key success factors for OTC

Products sold by positioning

Lax regulation causes both benefits and problems for OTC performance

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2010
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Healthcare Switches 2009-2011

SOURCES

  • Summary 2 Research Sources

Consumer Health in Guatemala - Company Profiles

Corp Lancasco SA in Consumer Health (Guatemala)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 4 Corp Lancasco SA: Competitive Position 2011

Farmamédica SA in Consumer Health (Guatemala)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 6 Farmamédica, SA: Competitive Position 2011

Laboratorios Laprin SA in Consumer Health (Guatemala)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 8 Laboratorios Laprin SA: Competitive Position 2011

Adult Mouth Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011 current value sales of adult mouth care products reached GTQ204,000 after a 6% increase. Despite this apparently high percentage growth rate, given the small market size, per capita consumption remains stagnant. Availability of UTC or Rx products, plus the lack of traditional usage of this kind of product, limits the category’s market size.

SWITCHES

COMPETITIVE LANDSCAPE

  • The most important brand in the category is Pyralvex Berna by Desma Healthcare, which accounts for 86% share of current value sales. The company has not invested in promoting the brand or even in refreshing its image. The bottle and its label are very outdated, but the brand still holds high top of mind recall which enables it to keep the leading position.

PROSPECTS

  • Over the forecast period, sales of adult mouth care products are expected to experience a 3% constant value CAGR to reach GTQ236,000, by 2016. Per capita consumption will remain mostly stagnant and negligible on a country level. Performance of adult mouth care is affected by low interest towards consumption of this type of product plus availability of Rx or UTC options which are generally prescribed by a health professional.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares 2007-2011
  • Table 14 Adult Mouth Care Brand Shares 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Guatemala - Category Analysis

HEADLINES

TRENDS

  • As in many other categories of OTC products, marketing and advertising are very important for the performance of analgesics. In 2011 the category reached current value sales of GTQ106 million as a result of a 7% increase in sales. In order to keep analgesics strong, leading companies have focused on advertising, product segmentation and more recently, on combination formats. The latter is to attract customers whose purchasing decision is primarily based on performance; combination products can offer better and faster acting results than regular analgesics.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011, generic options continue to lead sales in the analgesics category, accounting for 28% of current value sales. Bayer de Centroamérica y El Caribe follows with a 27% share. This multinational has a longstanding presence in the country, so most of its brands have gained strong positioning over the years. The company is constantly innovating and is also very active in terms of advertising. In order to keep attracting new profitable customers, Bayer has focused on segmenting its latest product introductions. This way, the company is able to reach new customers and gain their loyalty.

PROSPECTS

  • Over the forecast period, analgesics is expected to grow at a constant value CAGR of 4% to GTQ126 million in 2016. Large multinationals are expected to remain very important, accounting for large market shares. Their strong position in the market is expected to keep favouring the entire category, as they are able to invest in research and development, further segmenting analgesics and thus creating new opportunities. Segmentation is expected to continue playing an important part in analgesics’ performance, as brands reach specific market niches with products designed to be used for specific ailments.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Analgesics Company Shares 2007-2011
  • Table 20 Analgesics Brand Shares 2008-2011
  • Table 21 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 22 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Use of OTC calming and sleeping products is limited in the country. The total market size of this category is GTQ850,800, making it one of the smallest categories in the consumer health market in the country. This market size was reached in 2011 after registering current value growth of 2%. Most OTC calming and sleeping products that are classified as standard include natural active ingredients such as passiflora.

SWITCHES

COMPETITIVE LANDSCAPE

  • Calming and sleeping remains highly fragmented, with small participants having small market shares of a small category. Competitors range from manufacturers of standard products, such as Roemmers de Centro América SA with its standard brand Dorixina Relax, to domestic manufacturer Infasa with its herbal/traditional option, Passinerva.

PROSPECTS

  • Over the forecast period, sales of calming sleeping products are expected to experience a 2% constant value CAGR to reach GTQ1 million by 2016. Consumers still have some perception issues, as many tend to regard self-medication of calming and sleeping products as something rather dangerous. Many consumers are expected to opt for UTC and Rx options that can be directly prescribed and supervised by a health professional.

CATEGORY DATA

  • Table 23 Sales of Calming and Sleeping: Value 2006-2011
  • Table 24 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 25 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 26 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011 cough, cold and allergy (hay fever) remedies reached GTQ103 million in current value sales after experiencing growth of 6%. The category is one of the largest in the total consumer health market in the country, accounting for 20% of total current value sales. With a rainy season that usually lasts from May to October, sales of cough, cold and allergy (hay fever) remedies peak, with more customers needing relief from allergies or coughs/colds during this period. With a 50% share of total current value sales, the largest category is combination products. This type of product is preferred since it provides multi-symptom relief.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Bayer Centroamérica y El Caribe continued to lead sales in the category, accounting for a 16% share of current value sales. The category is highly fragmented with many companies occupying small market shares. Generics also hold a strong position, accounting for a 24% share of current value sales. The strong position of Bayer and its brand Tabcin is mainly due to its longstanding presence in the country which has gained it a strong top of mind positioning. The company is also constantly innovating and promoting its products, preventing competitors from gaining market share.

PROSPECTS

  • Over the forecast period, the category is expected to experience a 5% constant value CAGR, driving constant value sales to GTQ130 million by 2016. Innovation could be the main source for potential growth in the category, as companies are able to capture more value via innovative formats that refresh the market.

CATEGORY DATA

  • Table 27 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 28 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 29 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares 2007-2011
  • Table 30 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares 2008-2011
  • Table 31 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 32 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011, digestive remedies grew by 13% to GTQ46 million in terms of current value sales. Performance among digestive remedies is benefited by poor eating habits, stress and poor sanitary conditions. Water quality is also a major issue causing people to get digestive illnesses. Given the socioeconomic conditions of the country, not all the population is able to afford medicine, so the government sometimes provides these for free. For example, in October 2010 the government announced the distribution of Zinc pills that could help treat digestive illnesses, which would be distributed through public health institutions. Digestive diseases are responsible for around 3% of total deaths in the country every year, but the percentage has declined over the years, thanks to increased access to health care and higher health awareness.

SWITCHES

COMPETITIVE LANDSCAPE

  • With a 25% share of value sales, Bayer Centroamérica y El Caribe is the category leader, followed by GlaxoSmithKline Guatemala with an 18% share. Their umbrella brands Alka Seltzer (Bayer) and Sal Andrews (GSK) are the main leading brands in the category. These companies have strong support for their brands; investing heavily to maintain good positioning. Distribution is also very important for these products’ success.

PROSPECTS

  • Performance over the forecast period is expected to be strong, with predicted GTQ62 million by 2016 thanks to a 6% constant value CAGR. Antacids is expected to continue leading sales, representing around 76% of constant value sales by 2016. Popularity of this type of product is expected to remain strong, given current and expected dietary concerns among the Guatemalan population.

CATEGORY DATA

  • Table 33 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 34 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 35 Digestive Remedies Company Shares 2007-2011
  • Table 36 Digestive Remedies Brand Shares 2008-2011
  • Table 37 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 38 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Current value sales grew by 13% to GTQ1 million in 2011. This is one of the smallest OTC categories in the country. It is not common for customers to buy OTC ear care. Instead, they will most likely refer to a health specialist who will then prescribe a medicine. As a whole, ear care shows strong growth mainly as a result of a small actual market size, but it lacks real dynamism.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 201l, ear care continued to be fragmented between many small competitors. Dynamism was very limited, with many brands having other interests in the OTC market and giving limited importance to this small category.

PROSPECTS

  • With an expected 4% constant value CAGR, ear care could reach sales of GTQ2 million by 2016. With little dynamism and innovation and a lack of tradition for use, growth is expected to mostly come from population growth and price increases. Growth in terms of price is expected to remain moderate in order to have a positive impact on volume performance.

CATEGORY DATA

  • Table 39 Sales of Ear Care: Value 2006-2011
  • Table 40 Sales of Ear Care: % Value Growth 2006-2011
  • Table 41 Forecast Sales of Ear Care: Value 2011-2016
  • Table 42 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Eye care is a very small category in the overall consumer healthcare market, accounting for around GTQ1 million in current value terms. In 2011 the category grew by 7%. Growth in eye care can be explained by two main reasons. The first is that it is very small in actual terms, so small increases in actual numbers are reflected by high percentage changes. Additionally, the category has been favoured by an increased prevalence of eye related ailments, thanks to higher pollution, especially in Guatemala City. Other demographic changes, as a higher use of computers among a larger group of the population can also contribute to eye care’s strong performance.

SWITCHES

COMPETITIVE LANDSCAPE

  • In 2011 Pfizer Guatemala SA continued to be the leader of eye care, with its brand Visina accounting for a 33% share of value sales. Following relatively close was GlaxoSmithKline Guatemala with its brand EyeMo II. Both brands/manufacturers have been present in the market for a long time, so they have gained important recognition among key consumers.

PROSPECTS

  • Constant value sales of eye care products are expected to experience a 4% constant value CAGR to reach almost GTQ2 million in sales by 2016. Growth in eye care is expected to be a result of two main issues: Higher prevalence of eye related ailments due to growing urbanisation and a larger consumer base. Eye care can expand via population growth as well as by attacking previously untapped segments, which are expected to have higher disposable incomes over the forecast period.

CATEGORY DATA

  • Table 43 Sales of Eye Care by Category: Value 2006-2011
  • Table 44 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 45 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 46 Standard Eye Care by Positioning 2007-2011
  • Table 47 Eye Care Company Shares 2007-2011
  • Table 48 Eye Care Brand Shares 2008-2011
  • Table 49 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 50 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011, current value sales of herbal/traditional products grew by 11% to GTQ33 million. The category’s performance is mainly boosted by herbal cough, cold and allergy (hay fever) remedies together with herbal/traditional vitamins and dietary supplements, which together account for 81% of current value sales. Many consumers of herbal/traditional products opt to consume unpackaged options, which are found through informal channels. When switching to packaged consumer health care products, most consumers opt for standard products, which have a stronger level of positioning and are commonly regarded as more effective.

COMPETITIVE LANDSCAPE

  • The competitive landscape for herbal/traditional products in Guatemala is still highly fragmented, with no brands having important market shares or positioning among consumers.

PROSPECTS

  • Constant value sales of GTQ43 million are expected to be reached by 2016 with a CAGR of 5% over the forecast period. Per capita consumption is predicted to increase over the forecast period, although it will remain low on a country level, with more people trusting standard OTC options.

CATEGORY DATA

  • Table 51 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 52 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 53 Herbal/Traditional Products Company Shares 2007-2011
  • Table 54 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 55 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 56 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Current value sales of medicated skin care reached GTQ15 million in 2011 after a 10% increase in current value terms. Topical antifungals was the largest subcategory, accounting for 40% of total current value sales. Medicated skin care consists of several types of products, but it is more highly concentrated in antifungals.

SWITCHES

COMPETITIVE LANDSCAPE

  • Schering-Plough SA de CV is the leading company in medicated skin care with a 27% share of current value sales in the category. The leading position is due to the topical and vaginal antifungal brands that the company sells in the country, Icaden and Icaden Vaginal. The company leads the largest category, antifungals, which is why it also leads overall medicated skin care.

PROSPECTS

  • Constant value sales of medicated skin care are expected to reach GTQ18 million by 2016 after a 4% constant value CAGR. Certain categories might benefit from the country’s demographics and changing economic conditions. Increased prevalence of double-income homes might benefit subcategories such as vaginal antifungals or nappy/diaper rash treatments. The latter can also be boosted by consistent population growth and also by a large population that can use this type of product; by 2016 about 14% of the total population is expected to be aged 0-4-years-old.

CATEGORY DATA

  • Table 57 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 58 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 59 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 60 Medicated Skin Care Brand Shares 2008-2011
  • Table 61 Hair Loss Treatments Brand Shares 2008-2011
  • Table 62 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 63 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011 NRT smoking cessation aids grew by 6% to GTQ4 million in current value terms. Although growth is still important, it was affected by decreasing unit prices mainly coming from gum formats. In 2009 the Guatemalan Congress passed a smoking ban in the country. Although effects of this ban were not immediately felt, it can be concluded that lower unit prices in 2011 come as a result of companies aiming to increase their target market via price reductions. Enforcement for compliance with the smoking ban has been very low, so there is no real pressure on consumers to stop the habit, however, there is greater awareness of the potential health threats of smoking.

SWITCHES

COMPETITIVE LANDSCAPE

  • With its brand Nicorette, available both in patch and gum formats, GlaxoSmithKline Guatemala continues to be the single strongest participant in NRT smoking cessation aids, with an 85% share in current value terms.

PROSPECTS

  • Sales of NRT smoking cessation aids are expected to reach GTQ5 million by 2016 after a 6% constant value CAGR. Although Congress passed a smoking ban, observance of this law has been very low. Therefore, companies have not been able to capitalise on the passing of the law. However, it is expected that, as recently seen, smoking in public continues to be less socially acceptable, and health awareness continues to increase among consumers, giving them a reason to quit smoking. If this trend continues, it can be expected that sales can continue to grow strongly.

CATEGORY INDICATORS

  • Table 64 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 65 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 66 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 67 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 68 NRT Smoking Cessation Aids Company Shares 2007-2011
  • Table 69 NRT Smoking Cessation Aids Brand Shares 2008-2011
  • Table 70 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 71 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Guatemala - Category Analysis

HEADLINES

TRENDS

  • Current value sales of sports nutrition grew by 6% to GTQ15 million in 2011. The category continues to gain importance in Guatemala, especially among younger men who are more concerned with their physical appearance and health. Sports nutrition products tend to be linked with beauty, appealing to young adults, especially in urban areas.

COMPETITIVE LANDSCAPE

  • In 2011, GNC Guatemala, SA continued to be the leading company, with a 72% share of current value sales. Distribution and high brand recognition were the main reasons of the company’s great success. Positioning of the brand and its products is very good for sports nutrition, especially since this is the only competitor to invest in advertising and promotion on a large scale.

PROSPECTS

  • Constant value sales are expected to reach GTQ18 million by 2016 after a 3% constant value CAGR. Sports nutrition still has major potential for growth which is only hindered by low purchasing power of a large percentage of the population. However, an increase in job opportunities for key consumer groups is expected to positively affect sales, as higher disposable incomes in the group boost performance.

CATEGORY DATA

  • Table 72 Sales of Sports Nutrition: Value 2006-2011
  • Table 73 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 74 Sports Nutrition Company Shares 2007-2011
  • Table 75 Sports Nutrition Brand Shares 2008-2011
  • Table 76 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 77 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011, vitamins and dietary supplements was able to grow by 6% to reach GTQ200 million current value sales. Multivitamins remained the largest category with current value sales equivalent to 47% of total vitamins and dietary supplements current value sales. With a large market size, vitamins and dietary supplements is one of the largest categories in consumer health in Guatemala. People tend to trust vitamins and dietary supplement products, not only as preventive medicine but also as a way to treat existing ailments.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • In 2011, GNC Guatemala SA continued to lead sales of vitamins and dietary supplements, accounting for 14% of value sales. Most of GNC’s strength comes from its leadership in vitamins, where it accounts for a 20% share of value sales. The company has remained very active in terms of advertising and promotion. Key consumers of these products trust the brand and its different products, as well as advice that they can get from clerks in these stores.

PROSPECTS

  • Vitamins and dietary supplements is expected to experience a 3% constant value CAGR to reach sales of GTQ232 million by 2016. Although products in vitamins and dietary supplements have been present in Guatemala for a long period of time, their potential is still large, especially as different companies make an effort to grow by reaching previously untapped niches of the population. With a larger consumer base it can be expected that vitamins and dietary supplements’ performance remains strong.

CATEGORY DATA

  • Table 78 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 79 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 80 Dietary Supplements by Positioning 2007-2011
  • Table 81 Vitamins and Dietary Supplements Company Shares 2007-2011
  • Table 82 Vitamins and Dietary Supplements Brand Shares 2008-2011
  • Table 83 Vitamins Brand Shares 2008-2011
  • Table 84 Dietary Supplements Brand Shares 2008-2011
  • Table 85 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 86 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016
  • Summary 9 Dietary Supplements: Brand Ranking by Positioning 2010

Weight Management in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011, current value sales of weight management reached GTQ3 million after a 9% increase. Weight management is still incipient and sales are divided 49% to weight loss supplements, 45% to meal replacement slimming and the rest with other slimming products. Although obesity rates are increasing at high levels, use of this type of product is still not rooted in the population.

COMPETITIVE LANDSCAPE

  • With a 48% share of current value sales, Herbalife Guatemala continues to lead sales of weight management products. The company’s greatest strength comes from its leading position in the second most important category, meal replacement slimming products, which the company practically introduced to the country.

PROSPECTS

  • Over the forecast period weight management is expected to expand with a constant value CAGR of 7% and reach constant value sales of GTQ5 million by 2016. Weight management’s performance is mainly boosted by sales in urban areas of the country where consumers are more interested in watching their weight and can afford to use this type of method for that purpose. Additionally, obesity can have a higher prevalence among more developed areas of the country as a result of busier lifestyles which push consumers to unhealthy eating habits.

CATEGORY DATA

  • Table 87 Sales of Weight Management by Category: Value 2006-2011
  • Table 88 Sales of Weight Management by Category: % Value Growth 2006-2011
  • Table 89 Weight Management Company Shares 2007-2011
  • Table 90 Weight Management Brand Shares 2008-2011
  • Table 91 Forecast Sales of Weight Management by Category: Value 2011-2016
  • Table 92 Forecast Sales of Weight Management by Category: % Value Growth 2011-2016

Wound Care in Guatemala - Category Analysis

HEADLINES

TRENDS

  • In 2011, current value sales of wound care reached GTQ7 million after a 6% increase in current value terms. One of the key groups of consumers of wound care products are children. In Guatemala demographics favour the performance of wound care, with around 42% of the population aged between 0-14-years of age. This large young population provides the category with a large current consumer base.

COMPETITIVE LANDSCAPE

  • In 2011, BDF Centroamérica SA and its brand Hansaplast continued to lead sales of wound care in Guatemala. The company held a 66% share of current value sales, followed by 3M Guatemala SA with only 12% share of market. Hansaplast has been the brand with stronger support in the category, also commonly being responsible for innovation.

PROSPECTS

  • With an expected 4% constant value CAGR, wound care is expected to reach constant value sales of GTQ9 million by 2016. Constant value sales are expected to be almost equally divided between the two subcategories: Sticking plasters/adhesive bandages with 45% of total constant value sales; and gauze, tape and other wound care with the remaining 55%. Since children tend to be key consumers of these products, Guatemala’s demographics are expected to help boost sales of wound care. Population growth in Guatemala is expected to remain consistent at around 2% per year, and children under 14 are expected to continue comprising around 39% of the population by 2016 providing a large potential market. The main factor affecting sales in the category is that a large percentage of the population lives in poverty, so access to specialised, high added value products can be out of reach for many.

CATEGORY DATA

  • Table 93 Sales of Wound Care by Category: Value 2006-2011
  • Table 94 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 95 Wound Care Company Shares 2007-2011
  • Table 96 Wound Care Brand Shares 2008-2011
  • Table 97 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 98 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health
    • OTC
      • Adult Mouth Care
      • Analgesics
        • Systemic Analgesics
          • Adult Analgesics
            • Acetaminophen
            • Aspirin
            • Combination Products - Analgesics
            • Diclofenac
            • Dipyrone
            • Ibuprofen
            • Ketoprofen
            • Naproxen
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
        • Topical Analgesics/Anaesthetic
      • Calming and Sleeping
      • Cough, Cold and Allergy (Hay Fever) Remedies
        • Antihistamines/Allergy Remedies (Systemic)
        • Paediatric Cough, Cold and Allergy Remedies
          • Paediatric Allergy Remedies
          • Paediatric Cough/Cold Remedies
        • Combination Products - Cough, Cold and Allergy (Hay Fever) Remedies
        • Cough Remedies
        • Decongestants
          • Nasal Sprays
          • Oral Decongestants
          • Inhalant Decongestants
          • Decongestant Rubs
          • Nasal Decongestant Drops
          • Nasal Decongestant Plasters
        • Medicated Confectionery
        • Pharyngeal Preparations
      • Digestive Remedies
        • Paediatric Digestive Remedies
          • Paediatric Diarrhoeal Remedies
          • Paediatric Indigestion and Heartburn Remedies
          • Paediatric Laxatives
          • Paediatric Motion Sickness Remedies
        • Diarrhoeal Remedies
        • IBS Treatments
        • Indigestion and Heartburn Remedies
          • Antacids
          • Antiflatulents
          • Digestive Enzymes
          • H2 Blockers
          • Proton Pump Inhibitors
        • Laxatives
        • Motion Sickness Remedies
      • Ear Care
      • Emergency Contraception
      • Eye Care
        • Allergy Eye Care
        • Standard Eye Care
      • Medicated Skin Care
        • Medicated Shampoos
        • Topical Antifungals
        • Vaginal Antifungals
        • Hair Loss Treatments
        • Nappy (Diaper) Rash Treatments
        • Antiparasitics/Lice (Head and Body) Treatments
        • Antipruritics
        • Paediatric Medicated Skin Care
        • Cold Sore Treatments
        • Haemorrhoid Treatments
        • Topical Allergy Remedies/Antihistamines
        • Topical Germicidals/Antiseptics
      • NRT Smoking Cessation Aids
        • NRT Gum
        • NRT Inhalators
        • NRT Lozenges
        • NRT Patches
        • Other NRT
      • OTC Triptans
      • Wound Care
        • First Aid Kits
        • Sticking Plasters/Adhesive Bandages
        • Gauze, Tape and Other Wound Care
    • Sports Nutrition
      • Protein Products
        • Bars
        • Powder
        • RTD
        • Other Protein
      • Non-Protein Products
    • Vitamins and Dietary Supplements
      • Paediatric Vitamins and Dietary Supplements
      • Dietary Supplements
        • Combination Dietary Supplements
        • Herbal/Traditional Dietary Supplements
          • Combination Herbal/Traditional Dietary Supplements
          • Echinacea
          • Evening Primrose Oil
          • Garlic
          • Ginkgo Biloba
          • Ginseng
          • St John's Wort
          • Other Herbal/Traditional Dietary Supplements
          • Non-Herbal Dietary Supplements
            • Calcium Supplements
            • Co-Enzyme Q10
            • Combination Non-Herbal Dietary Supplements
            • Eye Health Supplements
            • Fish Oils
              • Cod Liver Oil
              • Other Fish Oils
            • Glucosamine
            • Mineral Supplements
            • Omega-3-6-9 (Fish and Non-Fish)
            • Probiotic Supplements
            • Protein Powder
            • Royal Jelly
            • Sam-E
            • Other Non-Herbal Dietary Supplements
          • Tonics and Bottled Nutritive Drinks
          • Vitamins
            • Multivitamins
            • Single Vitamins
              • Vitamin A
              • Vitamin B
              • Vitamin C
              • Vitamin D
              • Vitamin E
              • Other Single Vitamins
        • Weight Management
          • Meal Replacement Slimming
          • OTC Obesity
          • Slimming Teas
          • Weight Loss Supplements
          • Other Slimming Products
        • Herbal/Traditional Products
          • Herbal/Traditional Analgesics
          • Herbal/Traditional Calming and Sleeping Products
          • Herbal/Traditional Cough, Cold and Allergy (Hay Fever) Remedies
          • Herbal/Traditional Digestive Remedies
          • Herbal/Traditional Medicated Skin Care
          • Herbal/Traditional Medicinal Teas
          • Herbal/Traditional Smoking Cessation Aids
          • Herbal/Traditional Paediatric Dietary Supplements
          • Herbal/Traditional Dietary Supplements
          • Herbal/Traditional Tonics and Bottled Nutritive Drinks
        • Allergy Care
          • Allergy Eye Care
          • Antihistamines/Allergy Remedies (Systemic)
          • Paediatric Allergy Remedies
          • Topical Allergy Remedies/Antihistamines
        • Paediatric Consumer Health
          • Paediatric Analgesics
            • Paediatric Acetaminophen
            • Paediatric Aspirin
            • Paediatric Combination Products - Analgesics
            • Paediatric Diclofenac
            • Paediatric Dipyrone
            • Paediatric Ibuprofen
            • Paediatric Ketoprofen
            • Paediatric Naproxen
          • Paediatric Cough, Cold and Allergy Remedies
            • Paediatric Allergy Remedies
            • Paediatric Cough/Cold Remedies
          • Paediatric Digestive Remedies
            • Paediatric Diarrhoeal Remedies
            • Paediatric Indigestion and Heartburn Remedies
            • Paediatric Laxatives
            • Paediatric Motion Sickness Remedies
          • Paediatric Medicated Skin Care
          • Nappy (Diaper) Rash Treatments
          • Paediatric Vitamins and Dietary Supplements

      Statistics Included

      Statistics Included

      For each category and subcategory you will receive the following data in Excel format:

      From Passport

      • Market sizes
      • Company shares
      • Brand shares
      • Distribution
      • Analysis by format
      • Analysis by positioning
      • Analysis by type
      • Herbal/traditional vs standard
      • Pricing
      • Smoking population - number of adult smokers
      • Smoking prevalence - % of adult population

      Market size details:

      • Retail volume
      • Retail volume % growth
      • Retail volume per capita
      • Retail value retail selling price % growth
      • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price % growth
      • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
      • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY

      Methodology

      Methodology

      Global insight and local knowledge

      With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

      This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

      Industry specialists

      Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

      Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

      The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

      Country and regional analysts

      Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

      In-country research network

      To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

      Research Methodology

      Our research methods

      Each Euromonitor International industry report is based on a core set of research techniques:

      Desk research

      With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

      • National statistics offices governmental and official sources
      • National and international trade press
      • National and international trade associations
      • Industry study groups and other semi-official sources
      • Company financials and annual reports
      • Broker reports
      • Online databases
      • The financial, business and mainstream press

      Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

      Store checks

      Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

      • Place: We track products in all relevant channels, selective and mass, store and non-store
      • Product: What are innovations in products, pack sizes and formats?
      • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
      • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

      Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

      Trade survey

      Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

      Trade surveys allow us to:

      • Fill gaps in available published data per company
      • Generate a consensus view of the size, structure and strategic direction of the category
      • Access year-in-progress data where published sources are out of date
      • Evaluate the experts’ views on current trends and market developments

      In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

      Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

      Company analysis

      At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

      At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

      Forecasts

      Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

      Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

      Data validation

      All data is subjected to an exhaustive review process, at country, regional and global levels.

      The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

      Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

      Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

      Market analysis

      Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

      Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

      my pages

      Want to find out more about this report?

      If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!